Cancer Prevention & Control Program (CPCP)

The actively developing Cancer Prevention and Control Program (CPCP) at the Fred & Pamela Buffett Cancer Center endeavors to support our interdisciplinary teams of preclinical, clinical and translational scientists to achieve national and international leadership in: 1) identifying and mitigating biologic, behavioral, and social factors that increase susceptibility to cancer; and 2) reducing cancer burden in patients and communities through novel and rigorous scientific approaches that identify and modulate biopsychosocial factors, treatments, and symptom assessment and management strategies.

CPCP scientists will lead in the following areas across the cancer continuum:

Program Leaders:

Raymond Bergan, MD

Raymond Bergan, MD
Deputy Director Buffett Cancer Center
rbergan@unmc.edu

Robin M. Lally, PhD, MS, RN, AOCN, FAAN

Robin M. Lally, PhD, MS, RN, AOCN, FAAN
Bertha L. Pankratz Professor of Nursing, Buffett Cancer Center Member
robin.lally@unmc.edu

Quan Ly, MD FACS

Quan Ly, MD FACS
Professor Surgery, Medical Director for Werner Hospital Progressive Care Unit
qly@unmc.edu

Rachael Schmidt

Rachael Schmidt, DNP, APRN, AOCNP
Cancer Survivorship & Risk/Prevention Program Director
raschmidt@nebraskamed.com

Shinobu Watanabe-Galloway, PhD

Shinobu Watanabe-Galloway, PhD
Professor, Associate Director Buffett Cancer Center Community Outreach & Engagement Office Research Director Behavioral Health Education Center of Nebraska
swatanabe@unmc.edu